Serra Ventures

Inprentus, Inc. is a nanotechnology company based in Champaign, Illinois, specializing in the design and manufacture of ultra-high precision diffraction gratings. Founded in 2012, the company produces X-ray and extreme ultraviolet (EUV) gratings that are utilized in synchrotron radiation facilities for applications in chemical analysis, imaging, and various research sectors, including photovoltaics, catalysis, and structural biology. Inprentus has developed an innovative manufacturing method for mechanically ruled blazed diffraction gratings, achieving high resolving power with minimal blaze angles. Their products serve a wide range of industries, including semiconductor manufacturing, optical data communication, and advanced laser applications, enabling enhanced capabilities in spectrometers, monochromators, and laser instrumentation.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Inprentus, Inc. is a nanotechnology company based in Champaign, Illinois, specializing in the design and manufacture of ultra-high precision diffraction gratings. Founded in 2012, the company produces X-ray and extreme ultraviolet (EUV) gratings that are utilized in synchrotron radiation facilities for applications in chemical analysis, imaging, and various research sectors, including photovoltaics, catalysis, and structural biology. Inprentus has developed an innovative manufacturing method for mechanically ruled blazed diffraction gratings, achieving high resolving power with minimal blaze angles. Their products serve a wide range of industries, including semiconductor manufacturing, optical data communication, and advanced laser applications, enabling enhanced capabilities in spectrometers, monochromators, and laser instrumentation.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Inprentus, Inc. is a nanotechnology company based in Champaign, Illinois, specializing in the design and manufacture of ultra-high precision diffraction gratings. Founded in 2012, the company produces X-ray and extreme ultraviolet (EUV) gratings that are utilized in synchrotron radiation facilities for applications in chemical analysis, imaging, and various research sectors, including photovoltaics, catalysis, and structural biology. Inprentus has developed an innovative manufacturing method for mechanically ruled blazed diffraction gratings, achieving high resolving power with minimal blaze angles. Their products serve a wide range of industries, including semiconductor manufacturing, optical data communication, and advanced laser applications, enabling enhanced capabilities in spectrometers, monochromators, and laser instrumentation.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Phi Optics Inc. develops optical imaging systems for life sciences, medical diagnostics, nanotechnology, and semiconductor testing applications. It offers Quantitative Phase Imaging, a label-free, non-contact, and non-invasive imaging method for measuring nanoscale structures and dynamics via interferometry. The company was founded in 2009 and is based in Champaign, Illinois.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Inprentus, Inc. is a nanotechnology company based in Champaign, Illinois, specializing in the design and manufacture of ultra-high precision diffraction gratings. Founded in 2012, the company produces X-ray and extreme ultraviolet (EUV) gratings that are utilized in synchrotron radiation facilities for applications in chemical analysis, imaging, and various research sectors, including photovoltaics, catalysis, and structural biology. Inprentus has developed an innovative manufacturing method for mechanically ruled blazed diffraction gratings, achieving high resolving power with minimal blaze angles. Their products serve a wide range of industries, including semiconductor manufacturing, optical data communication, and advanced laser applications, enabling enhanced capabilities in spectrometers, monochromators, and laser instrumentation.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Inprentus, Inc. is a nanotechnology company based in Champaign, Illinois, specializing in the design and manufacture of ultra-high precision diffraction gratings. Founded in 2012, the company produces X-ray and extreme ultraviolet (EUV) gratings that are utilized in synchrotron radiation facilities for applications in chemical analysis, imaging, and various research sectors, including photovoltaics, catalysis, and structural biology. Inprentus has developed an innovative manufacturing method for mechanically ruled blazed diffraction gratings, achieving high resolving power with minimal blaze angles. Their products serve a wide range of industries, including semiconductor manufacturing, optical data communication, and advanced laser applications, enabling enhanced capabilities in spectrometers, monochromators, and laser instrumentation.

Phi Optics Inc. develops optical imaging systems for life sciences, medical diagnostics, nanotechnology, and semiconductor testing applications. It offers Quantitative Phase Imaging, a label-free, non-contact, and non-invasive imaging method for measuring nanoscale structures and dynamics via interferometry. The company was founded in 2009 and is based in Champaign, Illinois.

ANDalyze, Inc. is a company based in Champaign, Illinois, that specializes in developing innovative products for testing water contamination through catalytic DNA technologies. The company's offerings include the AND1100 Fluorimeter, a portable device designed for the rapid testing of heavy metals in water supplies, along with fluorescence-based sensors and kits. These products enable simple, fast, and cost-effective detection of trace metals and other chemicals, significantly reducing the time and expense associated with traditional testing methods. ANDalyze distributes its products both in the United States and internationally, providing solutions that enhance the efficiency and reliability of water quality testing. Formerly known as Dzyme Tech, the company rebranded to ANDalyze, Inc. in October 2009 and has been operational since its incorporation in 2005.